EPISODE · Nov 22, 2017 · 8 MIN
Recently Approved Drugs: Nivolumab for Metastatic Colorectal Cancer
from ASCO Education
Dr. Matthew Yurgelun, assistant professor of medicine at Harvard Medical School and gastrointestinal medical oncologist at the Dana Farber Gastrointestinal Cancer Center and Cancer Genetics and Prevention Program, presents information on the recently approved nivolumab for the treatment of patients 12 years and older with mismatch repair deficient and microsatellite instability high metastatic colorectal cancer.
Embed this episode
NOW PLAYING
Recently Approved Drugs: Nivolumab for Metastatic Colorectal Cancer
0:00
8:12
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of ASCO Education?
This episode is 8 minutes long.
When was this ASCO Education episode published?
This episode was published on November 22, 2017.
Can I download this ASCO Education episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!